Anticancer and bioactivity effect of the AraA-IL13 fusion protein on the glioblastoma cell line

• Glavni autori: Rezvan Mehrab (Autor), Hamid Sedighian (Autor), Fattah Sotoodehnejadnematalahi (Autor), Raheleh Halabian (Autor), Abbas Ali Imanifooladi (Autor)
• Format: Knjiga
• Izdano: Wolters Kluwer Medknow Publications, 2024-08-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background and purpose: Glioblastoma (GBM) is an aggressive and malignant brain cancer with the highest mortality and low survival rates. To discover a more specific and efficient treatment for GBM, we synthesized and examined the cytotoxic effect of arazyme-interleukin-13 (Ara-IL13) fusion protein...